Interest of FSL 2 in Recently Diagnosed Type 2 Diabetic Patients
NCT: NCT05676593 · TERMINATED
Brief Summary
Therapeutic patient education (TPE) is a key element in the management of people living with type 2 diabetes. The benefit of therapeutic education (TPE) has been clearly established on glycaemic control. Continuous interstitial glucose monitoring (CGM) can be considered as a TPE tool for people living with diabetes. A direct reading of the effects of diet and physical activity on glycaemic levels could have an impact on the initiation and maintenance of therapeutic lifestyle modifications. The investigators therefore propose a prospective randomised study in 2 arms : * a group of people living with diabetes receiving standard TPE vs * a group of people living with diabetes receiving standard TPE + FSL 28 days Ourmain objective is to determine the benefit of CGM on HbA1c at 3 months between 2 arms
Frequently Asked Questions
What is Interest of FSL 2 in Recently Diagnosed Type 2 Diabetic Patients?
Interest of FSL 2 in Recently Diagnosed Type 2 Diabetic Patients is a clinical trial registered under NCT05676593. Current status: TERMINATED.
What is the status of NCT05676593?
The current status of NCT05676593 (Interest of FSL 2 in Recently Diagnosed Type 2 Diabetic Patients) is: TERMINATED.
When did Interest of FSL 2 in Recently Diagnosed Type 2 Diabetic Patients start?
Interest of FSL 2 in Recently Diagnosed Type 2 Diabetic Patients started on 2023-05-03.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.